Based on the novel mechanism of ablation of the Notch1‐p15‐mediated tumor suppression in AML hyperproliferation, targeting ANXA1 provides an effective approach for AML treatment, in which antagonizing ANXA1 using NICD inhibitory peptides is an effective strategy for AML treatment. This evidence concerns the gene ANXA1 and acute myeloid leukemia.